Eric Floyd - 01 Jan 2022 Form 4 Insider Report for Virpax Pharmaceuticals, Inc. (VRPX)

Role
Director
Signature
/s/ Christopher Chipman, attorney-in-fact
Issuer symbol
VRPX
Transactions as of
01 Jan 2022
Net transactions value
$0
Form type
4
Filing time
05 Jan 2022, 16:22:25 UTC
Next filing
20 May 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VRPX Stock Option (right to buy) Award $0 +15,124 $0.000000 15,124 01 Jan 2022 Common Stock 15,124 $3.43 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.